About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

A judge is set to hear arguments about whether to honor the Department of Justice's request that corruption charges against ...

Discover how GLP-1 weight loss medications like Ozempic and Wegovy are linked to reduced risks of dementia heart disease and more—alongside potential side effects to consider ...

New data from Axios credits tough talk by Republicans led to fewer illegal border crossings and fewer arrests of unlawful ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

The best glasses for men both fit and flatter your face, are comfortable to wear and can stand up well to daily wear and tear. Our top pick overall is GlassesUSA, which makes high-quality ...

Lilly said on a call with analysts that it still believed there was huge demand for its weight-loss drug Zepbound and diabetes treatment Mounjaro from hundreds of millions of patients. The drugmaker's ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while its obesity treatment counterpart Zepbound brought in $1.9 ...